Suppr超能文献

突触前α-肾上腺素能受体生理作用的证据:在去大脑兔中对去甲肾上腺素释放的调节

Evidence for a physiological role of presynaptic alpha-adrenoceptors: modulation of noradrenaline release in the pithed rabbit.

作者信息

Majewski H, Hedler L, Starke K

出版信息

Naunyn Schmiedebergs Arch Pharmacol. 1983 Dec;324(4):256-63. doi: 10.1007/BF00502620.

Abstract

Rabbits were pithed and the preganglionic nerves at T 8 were stimulated continuously at a frequency of 3 Hz. 3H-noradrenaline was infused to reach a steady-state plasma level, from which the noradrenaline plasma clearance was calculated. The plasma level of endogenous noradrenaline was also determined and the rate of noradrenaline release into the plasma was then derived. The noradrenaline plasma clearance was decreased by guanethidine (7.5 mg/kg), desipramine (1 mg/kg), yohimbine (1 mg/kg) and rauwolscine (1 mg/kg). It was unaffected by corynanthine (1 mg/kg), prazosin (0.1 mg/kg), alpha-methylnoradrenaline (2 micrograms/kg per min) and clonidine (1 micrograms/kg per min). The electrical stimulation resulted in an increase in blood pressure without an increase in heart rate. Both adrenaline and noradrenaline were detected in the plasma. It is likely that the noradrenaline was of neuronal origin as guanethidine decreased its plasma level. The alpha 2-adrenoceptor-selective blocking drugs yohimbine and rauwolscine increased the noradrenaline release rate and only slightly decreased blood pressure. On the other hand, the alpha 1-adrenoceptor-selective blocking drugs corynanthine and prazosin had no effect on the noradrenaline release rate and decreased blood pressure more markedly. The alpha 2-adrenoceptor-selective agonists alpha-methylnoradrenaline and clonidine both decreased the noradrenaline release rate. This effect was blocked by yohimbine, and for the case of clonidine, not blocked by corynanthine. Plasma adrenaline levels were increased by yohimbine and rauwolscine, but not by corynanthine and prazosin. Clonidine reduced the plasma adrenaline level.(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

将兔子脊髓破坏后,以3Hz的频率持续刺激T8节段的节前神经。注入3H-去甲肾上腺素以达到稳态血浆水平,据此计算去甲肾上腺素的血浆清除率。同时测定内源性去甲肾上腺素的血浆水平,进而推算出去甲肾上腺素释放到血浆中的速率。胍乙啶(7.5mg/kg)、地昔帕明(1mg/kg)、育亨宾(1mg/kg)和萝芙素(1mg/kg)可降低去甲肾上腺素的血浆清除率。可洛宁(1mg/kg)、哌唑嗪(0.1mg/kg)、α-甲基去甲肾上腺素(每分钟2μg/kg)和可乐定(每分钟1μg/kg)对其无影响。电刺激导致血压升高但心率未增加。血浆中检测到肾上腺素和去甲肾上腺素。由于胍乙啶降低了其血浆水平,所以去甲肾上腺素可能源于神经元。α2-肾上腺素能受体选择性阻断药育亨宾和萝芙素增加了去甲肾上腺素的释放速率,且仅轻微降低血压。另一方面,α1-肾上腺素能受体选择性阻断药可洛宁和哌唑嗪对去甲肾上腺素释放速率无影响,但更显著地降低了血压。α2-肾上腺素能受体选择性激动剂α-甲基去甲肾上腺素和可乐定都降低了去甲肾上腺素的释放速率。此效应被育亨宾阻断,对于可乐定的情况,未被可洛宁阻断。育亨宾和萝芙素可增加血浆肾上腺素水平,但可洛宁和哌唑嗪则不然。可乐定降低了血浆肾上腺素水平。(摘要截短于250字)

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验